Fintel reports that on November 13, 2024, Leerink Partners downgraded their outlook for 908 Devices (NasdaqGM:MASS) from ...

Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on November 12. The company’s ...

Leerink downgraded 908 Devices (MASS) to Market Perform from Outperform with a price target of $4, down from $12. Though the firm still sees ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

On Wednesday, Talkspace Inc (TALK) stock saw a decline, ending the day at $3.3 which represents a decrease of $-0.07 or -2.08% from the prior close of $3.37. The stock opened at $3.42 and touched a ...

“We don’t know how successful it will be, but also note that this is a serious competitive threat being introduced to the ...

Jefferies has recently reiterated Teladoc Health Inc (TDOC) stock to Hold rating, as announced on September 17, 2024, according to Finviz. Earlier, on February 29, 2024, Cantor Fitzgerald had ...

HC Wainwright reissued their neutral rating on shares of Zura Bio (NASDAQ:ZURA – Free Report) in a report released on Monday ...

Other equities analysts also recently issued research reports about the company. Leerink Partnrs raised Tectonic Therapeutic to a “strong-buy” rating in a research report on Wednesday, July 24th.

Leerink Partners, a leading investment bank specializing in healthcare, announced today the addition of Grant Curry and Jason Truman to its biopharma M&A team. Both have joined Leerink as Senior ...